Myco TB
Proof of principle study: Detecting Mycobacterium tuberculosis
using a highly sensitive nucleic acid amplification based test on
stool samples obtained by rectal swabbing
Chief Investigator
|
Institution
|
Dates
|
Funding Stream
|
Amount
|
Dr Johanna Kellett-Wright |
University Hospitals Bristol and Weston NHS Foundation Trust
|
August 2022 to April 2024
|
Research Capability Funding Autumn 2021
|
£24,913 |
Summary
Tuberculosis (TB) is an infection which most commonly affects
the lungs and causes many deaths across the world. Diagnosing TB is
difficult, and some patients may require multiple expensive and
unpleasant investigations. This can result in delays to starting
treatment for TB, which can negatively affect their health, or
sometimes patients receive the incorrect treatment because a
diagnosis has not been confirmed. Current tests for TB may not give
results for several weeks and don't pick up all cases. There is a
need for better tests to help diagnosis of TB.
Nucleic Acid Amplification Tests (NAATs) are tests used to
diagnose many infections, including TB. NAATs are fast and work
well. People with TB often cough up secretions (sputum) and these
can be tested for TB by NAATs and other tests, but when patients
cannot produce sputum then other samples, such as stool or rectal
swabs, may be easier to obtain and could be tested for TB
too.
A new type of NAAT test has been developed to detect TB in animal
faeces. We want to investigate how well this new test works for
diagnosing TB in humans. Only a small amount of faecal material is
needed, therefore samples will be collected by patients with TB
using a rectal swab to see whether we can detect TB in their
stool.